Reliable Clinical Assessment through Multimodal AI

Modality.AI redefines how neurological and psychiatric conditions are assessed in clinical research. Our platform uses real-time audiovisual dialog with virtual guide "Tina" to capture and analyze speech, facial, and motor behavior — providing objective, reproducible data.

Designed for Rigorous Clinical Trials

The Modality Platform is built to meet the demands of regulated trials. It integrates seamlessly into clinical workflows and supports both in-clinic and remote administration. Sponsors use Modality to supplement (and in some instances, replace) rater-based assessments with automated measures that reduce subjectivity and increase statistical power.

Science-Driven, Clinically Validated

Modality’s protocols are grounded in decades of peer-reviewed research across ALS, Parkinson’s disease, schizophrenia, depression, autism and more. Our digital measures are designed to align with clinical endpoints and demonstrate sensitivity to disease progression and treatment response.

Real-World Use in Global Trials

Pharma and biotech sponsors, including top-10 biopharma, trust Modality to support studies whether observational cohorts, natural history studies FDA- and EMA-regulated clinical trials.

Multimodal. Objective. Reliable.

By combining speech, facial, and motor-movement analytics in a single session, Modality generates rich behavioral phenotypes in minutes. Data is processed in real-time, results are explainable and auditable.

Built by Experts

Modality is led by a team of neuroscientists, engineers, and clinicians with deep experience in AI, clinical trials, and CNS drug development. We collaborate closely with sponsors and sites to ensure that every study is designed and implemented for success.

Let’s Talk

Whether you’re planning a Phase 3 trial or an early-stage study, we would be happy to discuss how Modality can support your goals.

Contact us to schedule a demonstration to learn more.